# Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)

> **NCT02276482** · PHASE3 · COMPLETED · sponsor: **Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)** · enrollment: 120 (actual)

## Conditions studied

- Skin Diseases, Infectious
- Skin Diseases, Bacterial

## Interventions

- **DRUG:** Tedizolid Phophate
- **DRUG:** Antibiotic comparator
- **DRUG:** Aztreonam
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT02276482
- **Lead sponsor:** Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-25
- **Primary completion:** 2018-09-17
- **Final completion:** 2018-09-17
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02276482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02276482, "Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02276482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*